Oncogene Journal Citation Rate 2026
0950-9232
eISSN 1476-5594
Springer Nature
GB
Q1 Quartile Top Tier
About Oncogene
Oncogene (O) is a peer-reviewed academic journal, published by Springer Nature in GB. It is catalogued under ISSN 0950-9232 (electronic ISSN 1476-5594).
Oncogene Citation Rate 2026 — In Context
Oncogene has a 2025 2-Year Citation Rate (OpenAlex) of 5.61, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not a OpenAlex Journal Impact Factor.
Oncogene operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Oncogene should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Oncogene against similar journals in the field, use our journal comparison tool.
Submission Tips for Oncogene
- Budget $5490 for the Article Processing Charge. Check if your institution or funder covers OA fees.
| ISSN (Print) | 0950-9232 |
|---|---|
| ISSN (Online) | 1476-5594 |
| Publisher | Springer Nature |
| Country | United Kingdom |
| APC / Cost | $5490 USD |
In-depth profile & metrics
Oncogene is published by Springer Nature and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 5490.
Oncogene is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 5.609.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Oncogene
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 5.609 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment
Jessamy Adams, Caterina M. Suelzu, Gabriele Strusi • 2026
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S128439998
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.